A small crossover study found that prolonged fasting affected several metabolic steps differently. A single statement that fasting speeds or slows all midazolam metabolism would miss the findings.
Nine healthy participants received intravenous midazolam after an overnight fast, a thirty-six-hour fast, or a short high-fat dietary intervention. Prolonged fasting increased modeled parent-drug clearance by about twelve percent.
Apparent clearance measures for hydroxylated and glucuronidated products decreased. The high-fat intervention did not change systemic clearance under the tested conditions.
Metabolite parameters depend on both elimination and the fraction formed, and the model does not represent every nutritional or illness state. Intravenous dosing also avoids oral absorption effects.
The study cannot establish an individual impairment change or a universal diet-based dose correction. A forensic account should preserve duration and type of nutritional exposure, route, parent versus metabolite, and the model definition. Different concentration patterns need not imply inconsistent findings when they describe distinct steps in disposition.
Original analysis of the supplied journal article, identified as PMC6244726.